CARDINAL HEALTH INC News
Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
see moreCARDINAL HEALTH INC Market News
6d
Mizuho Raises Cardinal Health Price Target to $250 Amid Strong Earnings
- Mizuho increases Cardinal Health's price target to $250 following robust earnings.
24d
Cardinal Health's Strategic Acquisitions and Financial Growth Propel Stock Performance
Cardinal Health's strategic acquisitions and financial growth drive stock performance.
26 Jul at 18:33
Cardinal Health's Strategic Growth and Financial Performance Bolster Investor Confidence
Cardinal Health's strategic initiatives and strong financial performance enhance investor confidence.
19 Jul at 18:31
Cardinal Health's Strategic Initiatives and Financial Performance Drive Stock Momentum
Cardinal Health's strategic moves and strong financials boost stock performance.
12 Jul at 18:29
Cardinal Health's Strategic Moves Propel Stock to New Heights
Cardinal Health's strategic acquisitions and strong earnings drive stock surge.
07 Jul at 05:17
Cardinal Health Achieves Record Stock Price Amid Strong Financial Performance
Cardinal Health's stock reaches all-time high following robust earnings.
18 May at 04:15
Cardinal Health: Q3 Miss, Buybacks, Guidance Lift!
Cardinal Health reported a Q3 revenue shortfall and a $184M goodwill impairment, yet non-GAAP EPS rose and management raised FY2026 guidance while executing a $250M buyback—sparking a sharp share reaction amid continued analyst support.